May 10, 2023 11:31 AM EDT
People

Ic­ahn wins back­ing from share­hold­er ad­vi­so­ry firm in bid to re­move Il­lu­mi­na CEO from board

Jared Whitlock

Features Editor

Il­lu­mi­na’s CEO and board chair­man shouldn’t be re­elect­ed to the board of di­rec­tors, the proxy ad­vi­so­ry firm Glass Lewis said, giv­ing a tac­ti­cal vic­to­ry to …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Boehringer’s up­dat­ed re­sults in HER2-mu­tat­ed lung can­cer im­press

No­vavax re­sponds to FDA’s tri­al ask, with Covid vac­cine strain up­dates un­der scruti­ny

Mer­ck KGaA to buy rare can­cer biotech Spring­Works for $3.9B

GSK’s check­point block­er Jem­per­li cures bio­mark­er-dri­ven rec­tal can­cer

Schol­ar Rock names new CEO, adds biotech vet­er­ans in C-suite re­build

sponsored

Rev­o­lu­tion­iz­ing obe­si­ty treat­ment: Could mi­to­chon­dria hold the key to un­lock­ing fat-spe­cif­ic weight loss?

A service from the Financial Times